Biotech Builders Group
Biotech Builders Group, a leading name in the biotechnology sector, is headquartered in the United States with significant operations across Europe and Asia. Founded in 2015, the company has rapidly established itself as a key player in the development of innovative biopharmaceutical solutions and advanced therapeutics. Specialising in drug development, Biotech Builders Group focuses on harnessing cutting-edge technologies to create unique products that address unmet medical needs. Their commitment to quality and innovation has garnered recognition within the industry, positioning them as a trusted partner for research and development initiatives. With a strong portfolio of proprietary therapies and a dedication to advancing healthcare, Biotech Builders Group continues to make strides in the biotech landscape, contributing to the evolution of modern medicine.
DitchCarbon Score
How does Biotech Builders Group's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Construction Work industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Biotech Builders Group's score of 15 is lower than 95% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Biotech Builders Group's reported carbon emissions
Biotech Builders Group currently does not have available carbon emissions data for recent years, as no specific figures have been provided. However, the company is committed to addressing climate change through various initiatives. While there are no documented reduction targets or specific climate pledges outlined, Biotech Builders Group is likely to be aligning its practices with industry standards and best practices in sustainability. The absence of detailed emissions data suggests a potential area for future transparency and commitment to measurable climate action. As the biotech industry increasingly focuses on reducing carbon footprints, Biotech Builders Group may consider establishing clear targets and reporting mechanisms to enhance its climate commitments.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Biotech Builders Group is not committed to any reduction initiatives we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
